Matthew G Johnson
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 27, 2026
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.Hyoung Jin Kang, Antonio C Arrieta, Catharina Dhooge
|Mar 03, 2025
Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT study.Yoseph Caraco, Matthew G Johnson, Joseph A Chiarappa
|Apr 09, 2024
Molnupiravir: Mechanism of action, clinical, and translational science.Brian M Maas, Julie Strizki, Randy R Miller
|Feb 01, 2024
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT).Matthew G Johnson, Julie M Strizki, Erin Jensen
|Sep 12, 2023
Subgroup analysis of phase 2 study of ceftolozane/tazobactam in neonates and young infants with pyelonephritis.Emmanuel Roilides, John S Bradley, Julia Lonchar
|May 19, 2020
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosis.Antonio C Arrieta, Jocelyn Y Ang, Zufei Zhang
Pageof 1
Frequent Collaborators
2 joint publications
Julie Strizki
2 joint publications
Brian M Maas
1 joint publications
Emmanuel Roilides
1 joint publications
Christine Katlama
1 joint publications
Alfredo Ponce-de-León
1 joint publications
Chien-Yu Cheng
1 joint publications
Dorothy McCoy
1 joint publications
Mickie Cheng
1 joint publications
Carisa De Anda
1 joint publications
Matthew L Rizk
